Infliximab, azathioprine, or combination therapy for Crohn&apos;s disease.

Colombel, Jean Frédéric; Sandborn, William J; Reinisch, Walter; Mantzaris, Gerassimos J.; Kornbluth, Asher; Rachmilewitz, Daniel; Lichtiger, Simon; D'Haens, Geert R.A.M.; Diamond, Robert H; Broussard, Delma L.; Tang, Kezhen L; van der Woude, C. Janneke; Rutgeerts, Paul

doi:10.1056/NEJMoa0904492

Record: found
Abstract: found
Article: not found

Infliximab, azathioprine, or combination therapy for Crohn's disease.

Author(s): Jean Frédéric Colombel ¹ , William J Sandborn , Walter Reinisch , Gerassimos J Mantzaris , Asher Kornbluth , Daniel Rachmilewitz , Simon Lichtiger , Geert D'Haens , Robert H Diamond , Delma L Broussard , Kezhen L Tang , C Janneke van der Woude , Paul Rutgeerts

Publication date (Electronic): Apr 15 2010

Journal: The New England journal of medicine

Publisher: Massachusetts Medical Society

Read this article at

ScienceOpenPublisher PubMed

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The comparative efficacy and safety of infliximab and azathioprine therapy alone or in combination for Crohn's disease are unknown.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): N Engl J Med

Title: The New England journal of medicine

Publisher: Massachusetts Medical Society

ISSN (Electronic): 1533-4406

ISSN (Print): 0028-4793

Publication date (Electronic): Apr 15 2010

Volume: 362

Issue: 15

Affiliations

[1 ] Hôpital Claude Huriez and Centre d'Investigation Clinique, Centre Hospitalier Universitaire de Lille, Université Lille Nord de France, Lille, France. jfcolombel@chru-lille.fr

Article

Publisher Item ID: 362/15/1383

DOI: 10.1056/NEJMoa0904492

PubMed ID: 20393175

SO-VID: 9ea98b88-091f-4880-8f6f-1c4559ad23cb

History

Data availability:

Comments

Comment on this article

scite_

Cited by 741

See all cited by

- Version 1
- Version 1